Skip to main content

Neurogenic Bladder: Myelomeningocele, Occult Spina Bifida, and Tethered Cord

  • 705 Accesses

Part of the Urodynamics, Neurourology and Pelvic Floor Dysfunctions book series (UNPFD)

Abstract

Spinal dysraphism occurs in patients with spina bifida aperta or occulta and will affect the functionality of bladder and sphincter complex. The incidence has changed over the past decades from 1:3000 live births to 1:6000 as a result of the use of folic acid and also as a result of early abortion.

Treatment is directed to preservation of bladder and kidney function. As long as bladder volume with low pressures is achieved, kidney function will be fine. Low pressures are possible by using antimuscarinic medication or in some cases operations. Intermittent catheterization is needed to ensure proper bladder evacuation. In most cases, it is possible to become dry in between catheterization, or perhaps some incontinence remains during transfers or straining.

Colonic washouts have improved the quality of life dramatically: almost all patients can obtain pseudo-continence for stool.

Since a few years, it is possible to restore some sexual function by making a neural bypass between an ilioinguinal nerve and a dorsal nerve of the penis.

Attention for tethering and scarring of kidneys is the mainstay of the treatment.

Keywords

  • Spina Bifida Patients
  • Bladder Volume
  • Oxybutynin
  • Video Urodynamic Studies (VUDS)
  • Mirabegron

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Smith GK. The history of spina bifida, hydrocephalus, paraplegia, and incontinence. Pediatr Surg Int. 2001;17(5–6):424–32.

    CrossRef  PubMed  CAS  Google Scholar 

  2. Simpson D. Nicolaes Tulp and the golden age of the Dutch Republic. ANZ J Surg. 2007;77(12):1095–101.

    CrossRef  PubMed  Google Scholar 

  3. Akalan N. Myelomeningocele (open spina bifida) - surgical management. Adv Tech Stand Neurosurg. 2011;37:113–41.

    CrossRef  Google Scholar 

  4. Schorah C. Dick Smithells, folic acid, and the prevention of neural tube defects. Birth Defects Res A Clin Mol Teratol. 2009;85(4):254–9.

    CrossRef  PubMed  CAS  Google Scholar 

  5. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107(3):458–61.

    CrossRef  PubMed  CAS  Google Scholar 

  6. Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49(5):908–13.

    CrossRef  PubMed  Google Scholar 

  7. Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993–1004.

    CrossRef  PubMed  PubMed Central  CAS  Google Scholar 

  8. de Jong TP, Chrzan R, Klijn AJ, Dik P. Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol. 2008;23(6):889–96.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  9. Woodhouse CR. Myelomeningocele in young adults. BJU Int. 2005;95(2):223–30.

    CrossRef  PubMed  Google Scholar 

  10. Coulthard MG, Verber I, Jani JC, Lawson GR, Stuart CA, Sharma V, et al. Can prompt treatment of childhood UTI prevent kidney scarring? Pediatr Nephrol. 2009;24(10):2059–63.

    CrossRef  PubMed  Google Scholar 

  11. Veenboer PW, Hobbelink MG, Ruud Bosch JL, Dik P, van Asbeck FW, Beek FJ, et al. Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism. Neurourol Urodyn. 2015;34(6):513–8.

    CrossRef  PubMed  CAS  Google Scholar 

  12. Filler G, Gharib M, Casier S, Lodige P, Ehrich JH, Dave S. Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol. 2012;44(3):817–27.

    CrossRef  PubMed  Google Scholar 

  13. Choi EK, Shin SH, Im YJ, Kim MJ, Han SW. The effects of transanal irrigation as a stepwise bowel management program on the quality of life of children with spina bifida and their caregivers. Spinal Cord. 2013;51(5):384–8.

    CrossRef  PubMed  CAS  Google Scholar 

  14. Bauer SB, Joseph DB. Management of the obstructed urinary tract associated with neurogenic bladder dysfunction. Urol Clin North Am. 1990;17(2):395–406.

    PubMed  CAS  Google Scholar 

  15. Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010;52(8):749–53.

    CrossRef  PubMed  Google Scholar 

  16. Woodhouse CR, Neild GH, RN Y, Bauer S. Adult care of children from pediatric urology. J Urol. 2012;187(4):1164–71.

    CrossRef  PubMed  Google Scholar 

  17. Ahmad I, Granitsiotis P. Urological follow-up of adult spina bifida patients. Neurourol Urodyn. 2007;26(7):978–80.

    CrossRef  PubMed  Google Scholar 

  18. Husmann DA. Long-term complications following bladder augmentations in patients with spina bifida: bladder calculi, perforation of the augmented bladder and upper tract deterioration. Transl Androl Urol. 2016;5(1):3–11.

    PubMed  PubMed Central  Google Scholar 

  19. Zegers B, Uiterwaal C, Kimpen J, van Gool J, de Jong T, Winkler-Seinstra P, et al. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. J Urol. 2011;186(6):2365–70.

    CrossRef  PubMed  Google Scholar 

  20. Robinson JL, Finlay JC, Lang ME, Bortolussi R, Canadian Paediatric Society, Community Paediatrics Committee, Infectious Diseases and Immunization Committee. Prophylactic antibiotics for children with recurrent urinary tract infections. Paediatr Child Health. 2015;20(1):45–7.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  21. Defoor W, Ferguson D, Mashni S, Creelman L, Reeves D, Minevich E, et al. Safety of gentamicin bladder irrigations in complex urological cases. J Urol. 2006;175(5):1861–4.

    CrossRef  PubMed  Google Scholar 

  22. Durham SH, Stamm PL, Eiland LS. Cranberry products for the prophylaxis of urinary tract infections in pediatric patients. Ann Pharmacother. 2015;49(12):1349–56.

    CrossRef  PubMed  CAS  Google Scholar 

  23. Blais AS, Bergeron M, Nadeau G, Ramsay S, Bolduc S. Anticholinergic use in children: persistence and patterns of therapy. Can Urol Assoc J. 2016;10(3–4):137–40.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  24. Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012;2012:816274. https://doi.org/10.1155/2012/816274.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  25. Veenboer PW, Huisman J, Chrzan RJ, Kuijper CF, Dik P, de Kort LM, et al. Behavioral effects of long-term antimuscarinic use in patients with spinal dysraphism: a case control study. J Urol. 2013;190(6):2228–32.

    CrossRef  CAS  PubMed  Google Scholar 

  26. Nardulli R, Losavio E, Ranieri M, Fiore P, Megna G, Bellomo RG, et al. Combined antimuscarinics for treatment of neurogenic overactive bladder. Int J Immunopathol Pharmacol. 2012;25(1 Suppl):35S–41S.

    CrossRef  PubMed  CAS  Google Scholar 

  27. Morin F, Blais AS, Nadeau G, Moore K, Genois L, Bolduc S. Dual therapy for refractory overactive bladder in children: a prospective open-label study. J Urol. 2017;197(4):1158–63.

    CrossRef  PubMed  Google Scholar 

  28. Buyse G, Waldeck K, Verpoorten C, Bjork H, Casaer P, Andersson KE. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol. 1998;160(3 Pt 1):892–6.

    PubMed  CAS  Google Scholar 

  29. Staskin DR, Salvatore S. Oxybutynin topical and transdermal formulations: an update. Drugs Today (Barc). 2010;46(6):417–25.

    CrossRef  CAS  Google Scholar 

  30. Krause P, Fuhr U, Schnitker J, Albrecht U, Stein R, Rubenwolf P. Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study. J Urol. 2013;190(5):1791–7.

    CrossRef  PubMed  CAS  Google Scholar 

  31. Scheepe JR, Blok BF, ‘t Hoen LA. Applicability of botulinum toxin type A in paediatric neurogenic bladder management. Curr Opin Urol. 2017;27(1):14–9.

    CrossRef  PubMed  Google Scholar 

  32. Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol. 2008;53(5):1013–9.

    CrossRef  PubMed  CAS  Google Scholar 

  33. Highlights of prescribing information [Internet]. Available from: https://www.allergan.com/assets/pdf/botox_pi.pdf.

  34. Dik P, Klijn AJ, van Gool JD, de Jong TP. Transvaginal sling suspension of bladder neck in female patients with neurogenic sphincter incontinence. J Urol. 2003;170(2 Pt 1):580,1. discussion 581-2

    Google Scholar 

  35. Saikaly SK, Rich MA, Swana HS. Assessment of pediatric Malone antegrade continence enema (MACE) complications: effects of variations in technique. J Pediatr Urol. 2016;12(4):246.e1–6.

    CrossRef  Google Scholar 

  36. Veenboer PW, Nadorp S, de Jong TP, Dik P, van Asbeck FW, Bosch JL, et al. Enterocystoplasty vs detrusorectomy: outcome in the adult with spina bifida. J Urol. 2013;189(3):1066–70.

    CrossRef  PubMed  Google Scholar 

  37. Dik P, Tsachouridis GD, Klijn AJ, Uiterwaal CS, de Jong TP. Detrusorectomy for neuropathic bladder in patients with spinal dysraphism. J Urol. 2003;170(4 Pt 1):1351–4.

    CrossRef  CAS  PubMed  Google Scholar 

  38. Polm PD, de Kort, Laetitia M. O., de Jong, Tom P. V. M., Dik P. Langetermijn follow-up van katheteriseerbare vesicostoma’s bij kinderen, een vergelijking van verschillende technieken. Tijdschr Urol. 2017:1–4.

    Google Scholar 

  39. Veenboer PW, Bosch JL, van Asbeck FW, de Kort LM. Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review. PLoS One. 2012;7(10):e48399.

    CrossRef  PubMed  PubMed Central  CAS  Google Scholar 

  40. Ab E, Dik P, Klijn AJ, van Gool JD, de Jong TP. Detrusor overactivity in spina bifida: how long does it need to be treated? Neurourol Urodyn. 2004;23(7):685–8.

    CrossRef  PubMed  Google Scholar 

  41. Veenboer PW, Bosch JL, Rosier PF, Dik P, van Asbeck FW, de Jong TP, et al. Cross-sectional study of determinants of upper and lower urinary tract outcomes in adults with spinal dysraphism--new recommendations for urodynamic followup guidelines? J Urol. 2014;192(2):477–82.

    CrossRef  PubMed  Google Scholar 

  42. Marks BK, Goldman HB. Videourodynamics: indications and technique. Urol Clin North Am. 2014;41(3):383,91, vii-viii.

    CrossRef  Google Scholar 

  43. McGuire EJ, Woodside JR, Borden TA. Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study. J Urol. 1983;129(4):823–6.

    CrossRef  PubMed  CAS  Google Scholar 

  44. Snow-Lisy DC, Yerkes EB, Cheng EY. Update on urological management of spina bifida from prenatal diagnosis to adulthood. J Urol. 2015;194(2):288–96.

    CrossRef  PubMed  Google Scholar 

  45. von Linstow ME, Biering-Sorensen I, Liebach A, Lind M, Seitzberg A, Hansen RB, et al. Spina bifida and sexuality. J Rehabil Med. 2014;46(9):891–7.

    CrossRef  Google Scholar 

  46. Verhoef M, Barf HA, Vroege JA, Post MW, Van Asbeck FW, Gooskens RH, et al. Sex education, relationships, and sexuality in young adults with spina bifida. Arch Phys Med Rehabil. 2005;86(5):979–87.

    CrossRef  PubMed  Google Scholar 

  47. Overgoor ML, de Jong TP, Cohen-Kettenis PT, Edens MA, Kon M. Increased sexual health after restored genital sensation in male patients with spina bifida or a spinal cord injury: the TOMAX procedure. J Urol. 2013;189(2):626–32.

    CrossRef  PubMed  CAS  Google Scholar 

  48. Haakma W, Dik P, ten Haken B, Froeling M, Nievelstein RA, Cuppen I, et al. Diffusion tensor magnetic resonance imaging and fiber tractography of the sacral plexus in children with spina bifida. J Urol. 2014;192(3):927–33.

    CrossRef  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pieter Dik .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dik, P., de Kort, L.M.O., Veenboer, P.W. (2018). Neurogenic Bladder: Myelomeningocele, Occult Spina Bifida, and Tethered Cord. In: Mosiello, G., Del Popolo, G., Wen, J., De Gennaro, M. (eds) Clinical Urodynamics in Childhood and Adolescence. Urodynamics, Neurourology and Pelvic Floor Dysfunctions. Springer, Cham. https://doi.org/10.1007/978-3-319-42193-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42193-3_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42191-9

  • Online ISBN: 978-3-319-42193-3

  • eBook Packages: MedicineMedicine (R0)